Velan Capital Investment Management’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.42M Sell
2,099,652
-44,046
-2% -$75.1K 2.14% 13
2025
Q4
$3.82M Hold
2,143,698
2.21% 14
2025
Q3
$5.17M Buy
2,143,698
+1,239,669
+137% +$3.01M 4.85% 9
2025
Q2
$2.05M Hold
904,029
2.03% 16
2025
Q1
$2.43M Hold
904,029
2.5% 11
2024
Q4
$2.38M Hold
904,029
2.05% 10
2024
Q3
$2.42M Hold
904,029
2.27% 9
2024
Q2
$2.26M Hold
904,029
1.29% 11
2024
Q1
$2.14M Hold
904,029
0.97% 15
2023
Q4
$2.54M Hold
904,029
1.48% 14
2023
Q3
$2.96M Hold
904,029
2.38% 13
2023
Q2
$2.27M Buy
+904,029
New +$1.44M 2.11% 17

Other funds holding NSPR

Velan Capital Investment Management's NSPR Position: Q1 2026 in Review

Velan Capital Investment Management reduced its InspireMD (NSPR) stake by 2.1% in Q1 2026, selling an estimated $75.1K and leaving 2,099,652 shares worth $3.42M. The position accounts for 2.14% of the portfolio, ranked #13.

Velan Capital Investment Management first reported a position in NSPR in Q2 2023 and has held it in 12 quarters since. The position peaked at $5.17M in Q3 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Velan Capital Investment Management held 2,099,652 shares of InspireMD worth $3.42M as of Q1 2026.
  • Velan Capital Investment Management sold 44,046 InspireMD shares in Q1 2026, an estimated $75.1K.
  • InspireMD made up 2.14% of Velan Capital Investment Management's portfolio in Q1 2026, its #13 holding.
  • Velan Capital Investment Management first reported a position in InspireMD in Q2 2023 and has held it in 12 quarters since.
  • Velan Capital Investment Management's InspireMD position peaked at $5.17M in Q3 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.